<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03724825</url>
  </required_header>
  <id_info>
    <org_study_id>Adropin in obese men</org_study_id>
    <nct_id>NCT03724825</nct_id>
  </id_info>
  <brief_title>Correlation of Serum Adropin to Testosterone and Adiponectin in Obese Men</brief_title>
  <official_title>Correlation of Serum Adropin to Testosterone and Adiponectin in Obese Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aswan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aswan University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is associated with low testosterone in men and with dyslipidemia. Adropin hormone is
      negatively correlated with body mass index and is associated with dyslipidemia.

      correlation between adropin and testosterone will be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity, a worldwide epidemic is associated with multiple adverse health outcome as diabetes
      mellitus, hypertension and cardiovascular diseases caused mainly by dyslipidemia linked to
      obesity. Low testosterone levels in obese men were found associated with dyslipidemia.

      Adropin is a new metabolic hormone that was first isolated in liver and brain tissues, It was
      observed that mice fed on a high-fat diet (HFD) had a rapid increase in adropin expression
      compared to control values. In human also, adropin levels were negatively correlated with
      body mass index (BMI) and were associated with dyslipidemia.

      Adiponectin is a protein that is mainly produced by white adipose tissue and has an important
      role in lipid metabolism. Serum adiponectin concentrations were decreased in obese compared
      to normal weight men and significantly correlated with testosterone level.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Actual">January 7, 2020</completion_date>
  <primary_completion_date type="Actual">November 29, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>changes in lipid profile (TC, TG, LDL, HDL) levels</measure>
    <time_frame>6 months</time_frame>
    <description>expected higher TC, TG, LDl levels and lower HDL levels in obese men compared to normal</description>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in total testosterone levels</measure>
    <time_frame>6 months</time_frame>
    <description>expected lower testosterone levels in obese men compared to normal men</description>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in adropin level</measure>
    <time_frame>6 months</time_frame>
    <description>expected lower adropin levels in obese men compared to normal men</description>
  </primary_outcome>
  <primary_outcome>
    <measure>changed in adiponectin levels</measure>
    <time_frame>6 months</time_frame>
    <description>expected lower adiponectin level in obese men compared to normal men</description>
  </primary_outcome>
  <primary_outcome>
    <measure>correlation between adropin and testosterone</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>correlation between adropin and adiponectin</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">82</enrollment>
  <condition>Obesity</condition>
  <condition>Dyslipidemias</condition>
  <arm_group>
    <arm_group_label>obese men</arm_group_label>
    <description>Adult obese men (BMI ≥ 30 kg/m2)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal men</arm_group_label>
    <description>normal weight men (18.5 ≤ BMI &lt; 25 kg/m2 )</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>lipid profile: Total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL) and high density lipoprotein (HDL))</intervention_name>
    <description>blood samples will be collected after 10 hours fasting</description>
    <arm_group_label>normal men</arm_group_label>
    <arm_group_label>obese men</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Total testosterone</intervention_name>
    <description>blood samples will be collected after 10 hours fasting</description>
    <arm_group_label>normal men</arm_group_label>
    <arm_group_label>obese men</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Adropin</intervention_name>
    <description>blood samples will be collected after 10 hours fasting</description>
    <arm_group_label>normal men</arm_group_label>
    <arm_group_label>obese men</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Adiponectin</intervention_name>
    <description>blood samples will be collected after 10 hours fasting</description>
    <arm_group_label>normal men</arm_group_label>
    <arm_group_label>obese men</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        obese and normal weight men from 18 years to 50 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age from 18 years to 50 years. Clinically free except from obesity

        Exclusion Criteria:

          -  Diabetes mellitus Hypertension Heart failure Kidney disease Smoking
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Asmaa Abdelmageed Muhammed, Assistant lecturer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aswan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aswan University Hospital</name>
      <address>
        <city>Aswan</city>
        <zip>81528</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Canguven O, Talib RA, El Ansari W, Yassin DJ, Salman M, Al-Ansari A. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men. Andrologia. 2017 Dec;49(10). doi: 10.1111/and.12768. Epub 2017 Mar 10.</citation>
    <PMID>28295504</PMID>
  </reference>
  <reference>
    <citation>Ghoshal S, Stevens JR, Billon C, Girardet C, Sitaula S, Leon AS, Rao DC, Skinner JS, Rankinen T, Bouchard C, Nuñez MV, Stanhope KL, Howatt DA, Daugherty A, Zhang J, Schuelke M, Weiss EP, Coffey AR, Bennett BJ, Sethupathy P, Burris TP, Havel PJ, Butler AA. Adropin: An endocrine link between the biological clock and cholesterol homeostasis. Mol Metab. 2018 Feb;8:51-64. doi: 10.1016/j.molmet.2017.12.002. Epub 2017 Dec 30.</citation>
    <PMID>29331507</PMID>
  </reference>
  <reference>
    <citation>Yosaee S, Khodadost M, Esteghamati A, Speakman JR, Shidfar F, Nazari MN, Bitarafan V, Djafarian K. Metabolic Syndrome Patients Have Lower Levels of Adropin When Compared With Healthy Overweight/Obese and Lean Subjects. Am J Mens Health. 2017 Mar;11(2):426-434. doi: 10.1177/1557988316664074. Epub 2016 Aug 22.</citation>
    <PMID>27550773</PMID>
  </reference>
  <reference>
    <citation>Kim AY, Park YJ, Pan X, Shin KC, Kwak SH, Bassas AF, Sallam RM, Park KS, Alfadda AA, Xu A, Kim JB. Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance. Nat Commun. 2015 Jul 3;6:7585. doi: 10.1038/ncomms8585.</citation>
    <PMID>26139044</PMID>
  </reference>
  <reference>
    <citation>Thomas S, Kratzsch D, Schaab M, Scholz M, Grunewald S, Thiery J, Paasch U, Kratzsch J. Seminal plasma adipokine levels are correlated with functional characteristics of spermatozoa. Fertil Steril. 2013 Apr;99(5):1256-1263.e3. doi: 10.1016/j.fertnstert.2012.12.022. Epub 2013 Jan 30.</citation>
    <PMID>23375204</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 29, 2018</study_first_submitted>
  <study_first_submitted_qc>October 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2018</study_first_posted>
  <last_update_submitted>January 8, 2020</last_update_submitted>
  <last_update_submitted_qc>January 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aswan University Hospital</investigator_affiliation>
    <investigator_full_name>Asmaa Abdel-mageed Muhammed</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>Adropin</keyword>
  <keyword>adiponectin</keyword>
  <keyword>testosterone</keyword>
  <keyword>obese men</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

